Immunohistochemical analysis of tumor biopsies revealed an overall trend towards increased CD8+ T-cell infiltration following treatment with NHS-IL12, possibly the result of IL-12-induced T-cell proliferation [28,29]. This evidence concerns the gene CD8A and neoplasm.